Navigation Links
GPhA Says BIO Cries Wolf on Senate Biogenerics Proposal
Date:7/9/2009

ARLINGTON, Va., July 9 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger on The Biotechnology Industry Organization's (BIO's) erroneous claims regarding the Senate HELP Biogenerics amendments.

"BIO's erroneous claims that anything less than an unprecedented 13 years of market exclusivity will harm innovation flies in the face of the recent Federal Trade Commission (FTC) report that such long periods of exclusivity are NOT needed to spark innovation. In fact, FTC suggested that because of their extremely robust intellectual property protection in this sector, 'no' to little market exclusivity is required.

"Both the White House and the Office of Management and Budget (OMB) also specifically stated that an unprecedented 12 to 14 years of market exclusivity would NOT achieve what should be our shared goal of balancing pharmaceutical innovation and much needed consumer access.

"While the generic industry still supports the proven successful Hatch-Waxman model as contained in the bipartisan 'Promoting Innovation and Access to Lifesaving Medicines Act,' we have commended the President for working to move this issue forward by recommending a

7-year exclusivity compromise.

"Countless Americans are waiting for more affordable biogenerics to treat their serious medical conditions and it is clear that 12 to 14 years of exclusivity will do nothing to get them the help they desperately need.

"It is a shame that in an attempt to protect the profits of Amgen, Genentech and other biotech companies, BIO and its supporters are misleading Congress. It's time to put patients over profits."

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and
'/>"/>

SOURCE Generic Pharmaceutical Association (GPhA)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
2. Retired Supreme Court Justice Sandra Day OConnor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimers Disease
3. National ePrescribing Patient Safety Initiative Supports Senates Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
4. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
5. TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
6. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
7. Biogenerics Will Save Billions, Says Hospira CEO
8. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
9. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
10. CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
11. Hospira Supports Newly Introduced Biogenerics Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... November 17, 2014 Athena Signature Series: Turning ... Dr. Beverly Emerson, a professor in the Regulatory Biology Laboratory ... most recent discovery points to an “off switch” for drug ... and how her local research is making a global impact ... findings and then join host Cheryl K. Goodman, CEO of ...
(Date:11/18/2014)... FL (PRWEB) November 18, 2014 Brothers ... announced the launch of PAWSitively Curing Cancer, Inc ... This new 501(c) (3) non-profit organization is dedicated to ... donated goes directly to the University of Florida ... partner with PAWSitively Curing Cancer as the recipient of ...
(Date:11/18/2014)... INCLINE VILLAGE, Nev. , Nov. 18, 2014 /PRNewswire/ ... ) today announced that in connection with the acquisition ... approximately $42.7 million in connection with the termination of ... the full principal amount outstanding of $40 million, accrued ... October 2013, PDL entered into a structured financing transaction ...
(Date:11/18/2014)... 2014  Novira Therapeutics, Inc., a privately held biopharmaceutical ... hepatitis B virus (HBV) infection, today announced that ... Scientific Advisory Board (SAB).  "We are ... Christian S. Schade , Chief Executive Officer of Novira.  ... will be invaluable to Novira as our lead core ...
Breaking Biology Technology:PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3
... necessary for making a highly potent and clinically unexploited ... are antibiotic molecules produced by soil bacteria, and we ... which is active against many different pathogens," said Professor ... the paper to be published in PNAS. "Our ...
... are using the engineering technology behind the creation ... for the replacement of delicate and complex facial ... The researchers, combining engineering and plastic surgery ... optimization to design an experimental 3-D structure that ...
... July 12 /PRNewswire/ - Ocean Nutrition Canada (ONC) supplier ... supplement ingredients, announces today the acquisition of the exclusive global marketing ... , , , ... result of the agreement, ONC acquired the rights to exclusive use ...
Cached Biology Technology:Key milestone towards the development of a new clinically useful antibiotic 2High-performance engineering used to design facial bone replacements 2High-performance engineering used to design facial bone replacements 3Ocean Nutrition Canada Announces Acquisition of Exclusive License to GAT Food Essentials, Omega-3 Microencapsulation-Emulsion Technology 2Ocean Nutrition Canada Announces Acquisition of Exclusive License to GAT Food Essentials, Omega-3 Microencapsulation-Emulsion Technology 3
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
(Date:11/15/2014)... we may still be a few years away from the ... gain instant access to all that ailed his patients, mobile ... for monitoring and measuring our health are cropping up in ... tad Orwellian to some, but a new survey suggests that ... into their healthcare regime. These are some of ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... BEER-SHEVA, ISRAEL, February 17, 2011 Robotics researchers at ... million grant (977,840 ) to develop intelligent sensing and ... high value crops. The project is part of ... Robots for Crops). cRops will develop the scientific ...
... for the Advancement of Science (AAAS) has named Dr. ... the University of Colorado School of Medicine, as winner ... Technology Award., Cohen was honored for his outstanding achievements ... a series of free lectures on science and medicine, ...
... Four newly named beneficiaries of the Joshua E. ... new stem cell transplantation technology, the macroeconomics of ... The award recipients will receive partial financial support ... 2011 Annual Meeting of the American Association for ...
Cached Biology News:Ben-Gurion U. part of EU consortium to develop robots that selectively pick fruit 2Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 2Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 3Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 4Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science 2Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science 3
Request Info...
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Adducin beta (C-16)...
Geneticin Selective Antibiotic liquid...
Biology Products: